Capstone Investment Advisors’s Allergan plc AGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-68,800
| Closed | -$12.2M | – | 1392 |
|
|
2020
Q1 | $12.2M | Buy |
68,800
+3,700
| +6% | +$697K | 0.2% | 103 |
|
|
2019
Q4 | $12.4M | Buy |
65,100
+17,500
| +37% | +$3.16M | 0.07% | 299 |
|
|
2019
Q3 | $8.01M | Buy |
47,600
+9,600
| +25% | +$1.56M | 0.06% | 325 |
|
|
2019
Q2 | $6.36M | Buy |
38,000
+13,700
| +56% | +$1.9M | 0.05% | 400 |
|
|
2019
Q1 | $3.56M | Buy |
24,300
+13,000
| +115% | +$1.88M | 0.03% | 443 |
|
|
2018
Q4 | $1.51M | Buy |
11,300
+5,200
| +85% | +$852K | 0.02% | 512 |
|
|
2018
Q3 | $1.16M | Buy |
6,100
+5,800
| +1,933% | +$1.07M | 0.01% | 554 |
|
|
2018
Q2 | $50K | Buy |
+300
| New | +$48.2K | ﹤0.01% | 650 |
|
|
2017
Q2 | – | Sell |
-10,800
| Closed | -$2.58M | – | 1028 |
|
|
2017
Q1 | $2.58M | Hold |
10,800
| – | – | 0.06% | 234 |
|
|
2016
Q4 | $2.27M | Buy |
+10,800
| New | +$2.24M | 0.07% | 255 |
|
|
2016
Q3 | – | Sell |
-55,000
| Closed | -$12.7M | – | 970 |
|
|
2016
Q2 | $12.7M | Buy |
+55,000
| New | +$12.7M | 0.24% | 73 |
|
|
2016
Q1 | – | Sell |
-50,000
| Closed | -$15.6M | – | 806 |
|
|
2015
Q4 | $15.6M | Buy |
+50,000
| New | +$14.9M | 0.42% | 62 |
|
|
2015
Q3 | – | Sell |
-45,000
| Closed | -$13.7M | – | 451 |
|
|
2015
Q2 | $13.7M | Sell |
45,000
-5,000
| -10% | -$1.49M | 0.19% | 112 |
|
|
2015
Q1 | $14.9M | Sell |
50,000
-187,000
| -79% | -$53.3M | 0.24% | 83 |
|
|
2014
Q4 | $61M | Buy |
237,000
+216,500
| +1,056% | +$54.1M | 0.87% | 19 |
|
|
2014
Q3 | $4.95M | Buy |
+20,500
| New | +$4.59M | 0.06% | 221 |
|
|
2014
Q2 | – | Sell |
-106,100
| Closed | -$21.8M | – | 483 |
|
|
2014
Q1 | $21.8M | Buy |
106,100
+63,800
| +151% | +$12.6M | 0.28% | 63 |
|
|
2013
Q4 | $7.11M | Sell |
42,300
-21,400
| -34% | -$3.35M | 0.08% | 144 |
|
|
2013
Q3 | $9.17M | Buy |
63,700
+34,600
| +119% | +$4.61M | 0.09% | 120 |
|
|
2013
Q2 | $3.67M | Buy |
+29,100
| New | +$3.29M | 0.04% | 176 |
|
Other funds holding AGN
AJ
C
B
JJ
VFA
OPS
Capstone Investment Advisors's AGN Position: Q2 2020 in Review
Capstone Investment Advisors sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 91,010 shares — an estimated $16.1M sold.
Capstone Investment Advisors first reported a position in AGN in Q2 2013 and held it in 16 quarters. The position peaked at $106M in Q3 2019. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.
- Capstone Investment Advisors reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
- Capstone Investment Advisors sold 91,010 Allergan plc shares in Q2 2020, an estimated $16.1M.
- Capstone Investment Advisors first reported a position in Allergan plc in Q2 2013 and held it in 16 quarters.
- Capstone Investment Advisors's Allergan plc position peaked at $106M in Q3 2019.
- 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.
Based on Capstone Investment Advisors's 13F filing for Q2 2020, filed 14 Aug 2020.